Clinical Trials
2 trialsNCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT00674193 2017-05-17
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
Children's Oncology Group
Completed